Company Profile

Zacharon Pharmaceuticals Inc
Profile last edited on: 6/18/21      CAGE: 46BC7      UEI:

Business Identifier: Small molecule modulators of glycan synthesis and Sensi-Pro detection platform
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5626 Oberlin Drive Suite 100
San Diego, CA 92121
   (858) 459-9751
Location: Single
Congr. District: 52
County: San Diego

Public Profile

In January 2013, Zacharon Pharmaceuticals Inc was acquired by a former - but now much larger - SBIR awardee BioMarin. .Zacharon Pharmaceuticals, Inc. had been a biotechnology company working on discovery of first-in-class small molecule drugs that target glycans. Glycans, the carbohydrate chains of glycoproteins, proteoglycans, and glycolipids, represent a relatively unexploited area for drug development. Past attempts at developing drugs that target glycans have been limited by slow and expensive carbohydrate chemistry as well as the lack of effective glycan-targeted high-throughput screening methods. Zacharon created novel high-throughput screening methods to overcome these limitations and identify glycan-targeted small molecule drugs with strong efficacy and safety profiles. With the technology and glycobiology expertise, Zacharon could potentially be a key player in the field of glycan-targeted drug discovery with the potential to enhance drug development and guide clinical decision-making for diseases in which glycans are implicated in disease pathogenesis

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Robin M Jackman -- President

  Brett E Crawford -- Co-Founder and V.P. Research

  Charles E Glass -- Co-Founder and Senior V.P. Research